Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world.The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals.
It manufactures and supplies APIs for hair, skin, oral care; and anti-microbial preservatives for home and personal care market.The company offers contract manufacturing services and the manufacture of branded formulations.
It offers a comprehensive range of hair dye intermediates for permanent, semi-permanent and temporary hair coloring, photo chromic dyes, and imaging chemicals.It has presence in India, China, Mauritius, the UK, the US, Spain, and Mexico.
Vivimed is headquartered in Hyderabad,Telangana, India.
Vivimed Labs Ltd (VIVIMEDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The global Raman spectroscopy market is projected to reach USD 861 million by 2026 from an estimated USD 602 million in 2021, at a CAGR of 7.4% from 2021 to 2026. The Rise in adoption of Raman spectroscopy in clinical applications and advancement in utilization of Raman spectroscopic techniques for catalysts and catalytic reactions are among...
Cleanroom Technology Market Size, Share & Trends Analysis Report By Product (Consumables, Equipment), By End Use (Pharmaceutical Industry, Medical Device Industry), By Region, And Segment Forecasts, 2021 - 2028 Cleanroom Technology Market Growth & Trends The global cleanroom technology market...
Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production, Companion), By Product (Pharmaceuticals, Diagnostics), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2021 - 2028
Animal Health Market Growth & Trends
The global animal health market...
The latest report by the analyst titled, “Tartaric Acid Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” finds that the global tartaric acid market reached a value of US$ 2.55 Billion in 2020. Looking forward, the analyst expects the global tartaric acid market to exhibit moderate growth during the next...
The global seaweed market reached a production value of US$ 11.5 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 11.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end...
Myc Proto Oncogene Protein - Drugs In Development, 2021 Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) pipeline Target constitutes close to 23 molecules. Out of which approximately 18 molecules are developed by companies and remaining...
The South and Central America medical refrigerators market is expected to reach US$ 198.00 million by 2028 from US$ 139.98 million in 2021; it is estimated to grow at a CAGR of 5.1% from 2021 to 2028. The market growth is attributed to factors such as increasing demand for blood and blood components, technological advancements in medical...
120 pages •
By Infiniti Research Limited
• Jul 2021
Global Chlorine Market 2021-2025 The analyst has been monitoring the chlorine market and it is poised to grow by USD 5.88 bn during 2021-2025, progressing at a CAGR of 3.34% during the forecast period. Our report on the chlorine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges,...
This IDC Perspective illustrates how Debiopharm (a Swiss biopharmaceutical company) embarked on a digital transformation journey in which cybersecurity has become a top priority. This report highlights the key elements of this journey, including the adoption of artificial intelligence solutions to protect the intellectual property of its business...
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.